Cleveland Biolabs, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 16, 2021 at 07:31 am EDT
Cleveland BioLabs, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 669,237 compared to USD 592,191 a year ago. Net loss was USD 659,506 compared to USD 369,838 a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.03 a year ago. For the half year, operating loss was USD 1.220 million compared to USD 1.036 million a year ago. Net loss was USD 1.197 million compared to USD 958,370 a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.08 a year ago.